---
category: news
title: "Swiss artificial intelligence firm gains rights to first candidate"
excerpt: "Swiss drug discovery company Cureteq has in-licensed its first compound, from Germanyâ€™s Merck KGaA (MRK: DE). The clinical stage company is using artificial intelligence to help develop innovative medicines,"
publishedDateTime: 2022-05-30T11:54:00Z
originalUrl: "https://www.thepharmaletter.com/article/swiss-artificial-intelligence-firm-gains-rights-to-first-candidate"
webUrl: "https://www.thepharmaletter.com/article/swiss-artificial-intelligence-firm-gains-rights-to-first-candidate"
type: article
quality: 32
heat: 32
published: false

provider:
  name: The Pharma Letter
  domain: thepharmaletter.com

topics:
  - AI

secured: "oUOOOQDKo7XOBElv2NV2swXAqJEIuIROJQkTVmxtWpZ7BqKuZwkwMhL4uc8jyC/tknn/SGK5af+W9nUBiGUcmhUyYKchaZrXNZGk48LJDh6Haq7SgvLVd/hVgLaTFB30CinxAobvjflSyyUdriekN1sYuWtV1tFYW5mltJBV82yiyee2SjPHDVzMk/JFKEccbUmAiVqm4MvQuADEwjQRZzgovtZqakfRgMZo0hURcoMTa9PqBJHqUKPsUxVlyKz8M8VNesiffLJnb6LQXoDCfy2yJr5pzJiAlXBzaKVDQGzYawNesx4SNnJLbby7CrkfAFbqhOK8qRPBubM8byz+2KQ8aDQ6r+69HxD0BXuMSgk=;WeNZBE2v8k6VyEs1Zz+bZw=="
---

